Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Trabectedin
Therapeutic Area : Oncology
Study Phase : Approved FDF
Recipient : PharmaMar
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Under the agreement, Taiwan Toyo will distribute the new anti-cancer drug Yondelis (trabectedin), a newly synthesized anti-tumor drug derived from the sea squirt Ecteinascidia turbinata, in Taiwan, Hong Kong and Macau.
Product Name : Yondelis
Product Type : Cytotoxic Drug
Upfront Cash : Undisclosed
June 09, 2020
Lead Product(s) : Trabectedin
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Recipient : PharmaMar
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Reset All
